Found: 45
Select item for more details and to access through your institution.
Early clinical markers of aggressive multiple sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Defining secondary progressive multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Defining reliable disability outcomes in multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Comparative effectiveness in multiple sclerosis: A methodological comparison.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 326, doi. 10.1177/13524585231151394
- By:
- Publication type:
- Article
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 695, doi. 10.1177/1352458520936823
- By:
- Publication type:
- Article
Risk of secondary progressive multiple sclerosis: A longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 79, doi. 10.1177/1352458519868990
- By:
- Publication type:
- Article
Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 12, p. 1569, doi. 10.1177/1352458518798147
- By:
- Publication type:
- Article
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 12, p. 1617, doi. 10.1177/1352458517728812
- By:
- Publication type:
- Article
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 5, p. 642, doi. 10.1177/1352458517703800
- By:
- Publication type:
- Article
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1346, doi. 10.1177/1352458516679893
- By:
- Publication type:
- Article
Contribution of different relapse phenotypes to disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 2, p. 266, doi. 10.1177/1352458516643392
- By:
- Publication type:
- Article
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 4, p. 520, doi. 10.1177/1352458515594041
- By:
- Publication type:
- Article
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 9, p. 1159, doi. 10.1177/1352458514559865
- By:
- Publication type:
- Article
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Risk of relapse phenotype recurrence in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 11, p. 1511, doi. 10.1177/1352458514528762
- By:
- Publication type:
- Article
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 739, doi. 10.1177/1352458513507816
- By:
- Publication type:
- Article
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0122686
- By:
- Publication type:
- Article
Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. e63480
- By:
- Publication type:
- Article
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048078
- By:
- Publication type:
- Article
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038661
- By:
- Publication type:
- Article
Diagnostic difficulties in myasthenia gravis.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Motor neuron disease presenting as acute respiratory failure: electrophysiological studies.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
- Published in:
- CNS Drugs, 2021, v. 35, n. 11, p. 1217, doi. 10.1007/s40263-021-00860-7
- By:
- Publication type:
- Article
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 8, p. 789, doi. 10.1001/jamaneurol.2023.1625
- By:
- Publication type:
- Article
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 7, p. 739, doi. 10.1001/jamaneurol.2023.1542
- By:
- Publication type:
- Article
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 11, p. 1398, doi. 10.1001/jamaneurol.2020.2453
- By:
- Publication type:
- Article
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 11, p. 1407, doi. 10.1001/jamaneurol.2018.2109
- By:
- Publication type:
- Article
Comparison of Switch to Fingolimod or Interferon Beta/ Glatiramer Acetate in Active Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 4, p. 405, doi. 10.1001/jamaneurol.2014.4147
- By:
- Publication type:
- Article
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2013, v. 136, n. 12, p. 3609, doi. 10.1093/brain/awt281
- By:
- Publication type:
- Article
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
- Published in:
- Annals of Neurology, 2015, v. 77, n. 3, p. 425, doi. 10.1002/ana.24339
- By:
- Publication type:
- Article
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 6, p. 880, doi. 10.1002/ana.24287
- By:
- Publication type:
- Article
Corrections.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 6, p. 990
- By:
- Publication type:
- Article
Natalizumab effects on immune cell responses in multiple sclerosis.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 5, p. 748, doi. 10.1002/ana.20859
- By:
- Publication type:
- Article
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 4, p. 1014, doi. 10.1111/ene.15706
- By:
- Publication type:
- Article
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2321, doi. 10.1111/ene.15406
- By:
- Publication type:
- Article
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1082, doi. 10.1111/ene.14824
- By:
- Publication type:
- Article
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 9, p. 1163, doi. 10.1177/13524585241267211
- By:
- Publication type:
- Article
Predictors of disability worsening in clinically isolated syndrome.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 5, p. 479, doi. 10.1002/acn3.187
- By:
- Publication type:
- Article
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
- Published in:
- Canadian Journal of Neurological Sciences, 2013, v. 40, n. 4, p. 527, doi. 10.1017/S031716710001461X
- By:
- Publication type:
- Article
Treatment Optimization in Multiple Sclerosis.
- Published in:
- Canadian Journal of Neurological Sciences, 2004, v. 31, n. 2, p. 157, doi. 10.1017/S0317167100053804
- By:
- Publication type:
- Article
Letters to the editor.
- Published in:
- Muscle & Nerve, 1993, v. 16, n. 8, p. 876, doi. 10.1002/mus.880160814
- By:
- Publication type:
- Article
Needle electromyography of the diaphragm.
- Published in:
- Muscle & Nerve, 1992, v. 15, n. 6, p. 678, doi. 10.1002/mus.880150608
- By:
- Publication type:
- Article